{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:34:01Z","timestamp":1791232441841,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/s0145-2126(03)00259-5","type":"journal-article","created":{"date-parts":[[2003,10,9]],"date-time":"2003-10-09T04:37:07Z","timestamp":1065674227000},"page":"249-257","source":"Crossref","is-referenced-by-count":121,"title":["Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature"],"prefix":"10.1016","volume":"28","author":[{"given":"Alexander W","family":"Hauswirth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Simonitsch-Klupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Uffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(03)00259-5_BIB1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2559.1979.tb03017.x","article-title":"Mast cells and mast cell neoplasia: a review","volume":"3","author":"Lennert","year":"1979","journal-title":"Histopathology"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0344-0338(85)80184-9","article-title":"Tissue mast cells in health and disease","volume":"179","author":"Parwaresch","year":"1985","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB3","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB4","first-page":"385","article-title":"Biology, classification and treatment of human mastocytosis","volume":"108","author":"Valent","year":"1996","journal-title":"Wien Klin Wschr"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-198811000-00001","article-title":"Systemic mast cell disease. Analysis of 58 cases and literature review","volume":"67","author":"Travis","year":"1988","journal-title":"Medicine"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB6","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1111\/1523-1747.ep12468899","article-title":"Systemic mastocytosis: retrospective review of a decade\u2019s clinical experience at the Brigham and Women\u2019s Hospital","volume":"96","author":"Horan","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archderm.1963.01590140008002","article-title":"The natural course of urticaria pigmentosa","volume":"87","author":"Caplan","year":"1963","journal-title":"Arch. Dermatol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB8","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB10","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2001.02783.x","article-title":"Mutation analysis of c-kit in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis","volume":"113","author":"Fritsche-Polanz","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0301-472X(99)00145-9","article-title":"Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis","volume":"28","author":"Akin","year":"2000","journal-title":"Exp. Hematol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/mp.53.4.188","article-title":"Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukemia","volume":"53","author":"Sotlar","year":"2000","journal-title":"Mol. Pathol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2002-01-0203","article-title":"Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene","volume":"100","author":"Yavuz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB15","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB17","first-page":"1163","article-title":"Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases","volume":"22","author":"Mican","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1572-0241.1998.106_c.x","article-title":"Systemic mastocytosis: a rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis\u2014report of four cases","volume":"93","author":"Kyriakou","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB19","first-page":"260","article-title":"Pathologic fracture in systemic mastocytosis: radiographic spectrum and review of the literature","volume":"180","author":"Rafii","year":"1983","journal-title":"Clin. Orthop."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0002-9343(91)90214-I","article-title":"Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis","volume":"91","author":"Lawrence","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M","article-title":"Significance of systemic mast cell disease with associated hematologic disorders","volume":"62","author":"Travis","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2141.1990.tb07870.x","article-title":"Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders","volume":"76","author":"Horny","year":"1990","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10428190009058500","article-title":"Clinical and biologic diversity of leukemias occuring in patients with mastocytosis","volume":"37","author":"Sperr","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9","article-title":"Sequential immunophenotypic analysis of mast cells in a case of mast cell disease evolving to a mast cell leukamia","volume":"30","author":"Escribano","year":"1997","journal-title":"Cytometry"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/10428199609054789","article-title":"Treatment of three patients with systemic mastocytosis with interferon alpha-2b","volume":"22","author":"Worobec","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response to interferon alfa-2b in a patient with systemic mastocytosis","volume":"326","author":"Kluin-Nelemans","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB28","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/rheumatology\/35.9.898","article-title":"Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-26","volume":"35","author":"Lehmann","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s002770000271","article-title":"Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage","volume":"80","author":"Jost","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00663015","article-title":"Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b","volume":"72","author":"Weide","year":"1996","journal-title":"Ann. Hematol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2133.1998.02131.x","article-title":"Response of severe systemic mastocytosis to interferon alpha","volume":"138","author":"Butterfield","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2362.1995.tb01754.x","article-title":"Treatment of systemic mastocytosis with interferon-gamma: failure after appearance of anti-IFN-gamma antibodies","volume":"25","author":"Fiehn","year":"1995","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ajh.2830470121","article-title":"Long-term response to interferon-alpha in a patient with systemic mastocytosis and chronic myelomonocytic leukemia","volume":"47","author":"Pulik","year":"1994","journal-title":"Am. J. Hematol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1365-2133.1998.02190.x","article-title":"Tripe palms associated with systemic mastocytosis: the role of transforming growth factor-alpha and efficacy of interferon-alfa","volume":"138","author":"Chosidow","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s001050051006","article-title":"Systemische konnatale Mastozytose mit universeller Hautbeteiligung","volume":"50","author":"Krahl","year":"1999","journal-title":"Hautarzt"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM200101253440415","article-title":"Treatment of systemic mast-cell disease with cladribine","volume":"344","author":"Tefferi","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2133.1995.tb08689.x","article-title":"Interferon-alpha in combination with corticosteroids improves systemic mast cell disease","volume":"132","author":"Delaporte","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis: current treatment options and proposed response criteria","volume":"27","author":"Valent","year":"2003","journal-title":"Leuk Res."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB39","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic value of immunostaining for tryptase in patients with mastocytosis","volume":"22","author":"Horny","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","article-title":"Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis","volume":"25","author":"Sperr","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF01533368","article-title":"Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis","volume":"14","author":"Schwartz","year":"1994","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease","volume":"128","author":"Sperr","year":"2002","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB43","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0025-6196(12)62636-6","article-title":"Mast cell leukemia: report of a case and review of the literature","volume":"61","author":"Travis","year":"1986","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB44","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","article-title":"The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis","volume":"96","author":"Schwartz","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s002770000206","article-title":"Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitors in a patient with systemic mastocytosis","volume":"79","author":"Schernthaner","year":"2000","journal-title":"Ann. Hematol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB46","first-page":"5","article-title":"Biology of disease\u2014new insights into \u2018the riddle of the mast cells\u2019: microenvironmental regulation of mast cell development and phenotypic heterogeneity","volume":"62","author":"Galli","year":"1990","journal-title":"Lab. Invest."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB47","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1182\/blood.V84.9.2954.2954","article-title":"Origin of human mast cells: development from transplanted hemopoietic stem cells after allogeneic bone marrow transplantation","volume":"84","author":"F\u00f6dinger","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00259-5_BIB48","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB49","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","article-title":"Treatment of systemic mast cell disorders","volume":"14","author":"Worobec","year":"2000","journal-title":"Hematol. Oncol. N. Am."},{"key":"10.1016\/S0145-2126(03)00259-5_BIB50","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1172\/JCI119336","article-title":"Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems","volume":"99","author":"Finotto","year":"1987","journal-title":"J. Clin. Invest."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603002595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603002595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T19:02:48Z","timestamp":1623438168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212603002595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0145212603002595"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(03)00259-5","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}